SEC Form 4 · accession 0001127602-16-052275
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard F Wallman
Director
Period of report
May 12, 2016
Accepted (ET)
May 16, 2016 · 3:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 12, 2016 | A | 2,260 | $0.00 | A | 17,690 | D | |
| Common StockF2 | May 12, 2016 | A | 730 | $0.00 | A | 18,420 | D | |
| Common Stock | May 13, 2016 | S | 500 | $82.15 | D | 17,920 | D | |
| Common Stock | May 13, 2016 | S | 800 | $82.31 | D | 17,120 | D | |
| Common Stock | May 13, 2016 | S | 200 | $82.41 | D | 16,920 | D | |
| Common Stock | May 13, 2016 | S | 470 | $82.50 | D | 16,450 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of 2,260 unvested restricted stock units that vest upon the earlier of 5/12/2017 or the business day prior to the Company's next annual meeting of shareholders.
- F2This grant was made in lieu of cash director services fees for the term commencing May 11, 2016. The restricted stock units vest upon the earlier of 5/12/2017 or the business day prior to the Company's next annual meeting of shareholders.